Vontier Reports Second Quarter Results and Announces Agreement to Acquire Invenco
Go back to Vontier Reports Second Quarter Results and Announces Agreement to Acquire Invenco| Savient Pharmaceuticals, Inc. (NYSE: VNT) | Delayed: 32.86 -0.44 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.30 | 52 Week High | $9.92 | |||
| Open | $33.25 | 52 Week Low | $9.10 | |||
| Day High | $33.26 | P/E | N/A | |||
| Day Low | $32.47 | EPS | $-0.94 | |||
| Volume | 723,617 | |||||
